DailyDoctor Archive Specialties Get app
All pulmonology briefings

The edition · Pulmonology

Adaptive D-dimer thresholds ruled out pulmonary embolism with a 0.5% miss rate even in the 'adaptive window'

A meta-analysis of prospective management studies tests the patients whose D-dimer sits above 500 but below the adjusted cut-off. Also: seven in ten biologic-eligible severe asthma patients improved without a biologic, cryobiopsy for small peripheral lesions, and antifungals for ABPA in cystic fibrosis.

The edition in brief

A meta-analysis of six prospective management studies (12,194 patients) found that when age-adjusted or clinical-probability-adjusted D-dimer thresholds were used to withhold imaging, the three-month failure rate was 0.12% overall and 0.50% (95% CI 0.20–1.11%) in patients whose D-dimer lay between 500 ng/mL and the adaptive threshold, with no heterogeneity. In 10,078 UK adults with severe asthma newly eligible for biologics by exacerbation count, 70% improved to fewer than three exacerbations a year on standard care alone; persistently frequent exacerbators had higher eosinophil counts years earlier. In the Cryo-RCT (627 patients, Asia), cryobiopsy raised histological diagnostic yield for peripheral lesions up to 30 mm from 75% to 83%, at the cost of more moderate bleeding and pneumothorax. In 3,096 people with cystic fibrosis and ABPA, adding antifungals to oral corticosteroids was not associated with better lung function or fewer exacerbations.

In this edition

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for pulmonology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free